Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by gebremeskelon May 06, 2024 1:43pm
213 Views
Post# 36025350

RE:RE:RE:latest news release

RE:RE:RE:latest news releaseYou could always ask her - kaouthar.lbiati@gmail.com

She may not be at liberty to share much information. I would guess she is quietly working behind the scenes. Theralase was happy enough with her performance 7 months ago to grant her 300,000 options at 25 cents. 

She just had an interview in the online RootsandRoutesMag.Com which was founded by another member of the Moroccan diaspora. She doesn't get into any specifics. She just says, "I shifted gears in the last six years, to focus on mid-size companies and help them optimize their technology platforms, define their value proposition, secure funding, strategic partnerships, and/or licensing deals, to develop medicines that have the potential to reach patients worldwide."

https://www.rootsandroutesmag.com/kaouthar-lbiati-exclusive-interview/

Infinity wrote: I  was just wondering what the newest Director on the TLT Borad is  doing in terms of creating awareness for this Novel treatment using the PDT.  Have not heard anything from DR.Kaouthar Lbiati since was invited to an independant director.  She was appointed almost a year ago on 3rd June, 2023.  Not a word from her, No mention in her Twitter "X" account as well of this exciting, potential cure that she is part of the Leadership team.  Hopefully, she is working on a JV partner or increasing the clinical test sites behind the scenes that the TLT Management can not discuss openly?


<< Previous
Bullboard Posts
Next >>